Commentary

Podcast

Exploring the Importance of Biomarker Testing to Identify Genetic Variants, Correct Treatments

On this episode of Managed Care Cast, Kristine Ashcraft, president and founder of YouScript, explains the importance of biomarker testing to distribute proper treatments to patients and minimize adverse events.

On this episode of Managed Care Cast, we're talking with Kristine Ashcraft, the president and founder of YouScript, a tool that helps to predict adverse drug events and personalize patient care.

We discuss the lack of awareness of genetic variants among patients and the recent adoption of biomarker testing legislation in some states. This legislation will increase biomarker testing access, which will help providers to distribute the proper treatments to more patients based on identified genetic variants.

Listen above or on one of these podcast services:

iTunes
TuneIn
Stitcher
Spotify

Related Videos
Kelly Harris, APRN
Jessica K. Paulus, ScD, Ontada
Rachel Dalthorp, MD
Jessica K. Paulus, ScD, Ontada
Michael A. Choti, MD, MBA
Michael Thorpy, MD
Sindhuja Kadambi, MD, MS
Matthew Callister, MD
Jared Baeten
Rachel Dalthorp, MD
Related Content
CH LogoCenter for Biosimilars Logo